Table of Contents Author Guidelines Submit a Manuscript
International Journal of Vascular Medicine
Volume 2017, Article ID 2943467, 5 pages
https://doi.org/10.1155/2017/2943467
Research Article

ABO Gene Polymorphism and Thrombomodulin −33G>A Polymorphism Were Not Risk Factors for Myocardial Infarction in Javanese Men

1Department of Nursing, Faculty of Medicine, Brawijaya University, Malang, Indonesia
2Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia
3Department of Cardiology and Vascular Medicine, Faculty of Medicine, Brawijaya University, Malang, Indonesia

Correspondence should be addressed to Mohammad Saifur Rohman; moc.oohay@kneoppi

Received 21 February 2017; Revised 30 May 2017; Accepted 6 June 2017; Published 24 July 2017

Academic Editor: Bhagwan Satiani

Copyright © 2017 Mifetika Lukitasari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Yusuf, S. Reddy, S. Ôunpuu, and S. Anand, “Global burden of cardiovascular diseases. Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization,” Circulation, vol. 104, no. 22, pp. 2746–2753, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. J. C. Souto, L. Almasy, E. Muñiz-Diaz et al., “Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 8, pp. 2024–2028, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. M. E. Marenberg, N. Risch, L. F. Berkman, B. Floderus, and U. De Faire, “Genetic susceptibility to death from coronary heart disease in a study of twins,” The New England Journal of Medicine, vol. 330, no. 15, pp. 1041–1046, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. K. L. Wiggins, N. L. Smith, N. L. Glazer et al., “ABO genotype and risk of thrombotic events and hemorrhagic stroke,” Journal of Thrombosis and Haemostasis, vol. 7, no. 2, pp. 263–269, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. P. V. Jenkins and J. S. O'Donnell, “ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?” Transfusion, vol. 46, no. 10, pp. 1836–1844, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. O'Donnell and M. A. Laffan, “The relationship between ABO histo-blood group, factor VIII and von Willebrand factor,” Transfusion Medicine, vol. 11, no. 4, pp. 343–351, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. Y.-H. Li, J.-H. Chen, H.-L. Wu et al., “G-33A mutation in the promoter region of thrombomodulin gene and its association with coronary artery disease and plasma soluble thrombomodulin levels,” American Journal of Cardiology, vol. 85, no. 1, pp. 8–12, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. H.-Y. Park, T. Nabika, Y. Jang, H. M. Kwon, S. Y. Cho, and J. Masuda, “Association of G-33A polymorphism in the thrombomodulin gene with myocardial infarction in Koreans,” Hypertension Research, vol. 25, no. 3, pp. 389–394, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Yamada, H. Izawa, S. Ichihara et al., “Prediction of the risk of myocardial infarction from polymorphisms in candidate genes,” The New England Journal of Medicine, vol. 347, no. 24, pp. 1916–1923, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Zhao, X. Zhou, J. Huang, J. Chen, and D. Gu, “Association study of the thrombomodulin -33Ggt;A polymorphism with coronary artery disease and myocardial infarction in Chinese Han population,” International Journal of Cardiology, vol. 100, pp. 383–388, 2005. View at Publisher · View at Google Scholar
  11. Y.-H. Li, J.-H. Chen, W.-C. Tsai et al., “Synergistic effect of thrombomodulin promoter -33G/A polymorphism and smoking on the onset of acute myocardial infarction,” Thromb. Haemost, vol. 87, pp. 86–91, 2002. View at Google Scholar
  12. S. Al-Bustan, M. El-Zawahri, D. Al-Azmi, and A.-A. Al-Bashir, “Allele frequencies and molecular genotyping of the ABO blood group system in a Kuwaiti population,” International Journal of Hematology, vol. 75, no. 2, pp. 147–153, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Sharif, N. Anwar, T. Farasat, and S. Naz, “ABO blood group frequency in ischemic heart disease patients in Pakistani population,” Pakistan Journal of Medical Sciences, vol. 30, no. 3, pp. 593–595, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Biancari, J. Satta, R. Pokela, and T. Juvonen, “ABO blood group distribution and severity of coronary artery disease among patients undergoing coronary artery bypass surgery in Northern Finland,” Thrombosis Research, vol. 108, no. 2-3, pp. 195-196, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. M. He, B. Wolpin, K. Rexrode et al., “ABO blood group and risk of coronary heart disease in two prospective cohort studies,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 9, pp. 2314–2320, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Jukic, J. Bingulac-Popovic, V. Dogic et al., “Evaluation of ABO blood groups as a risk factor for myocardial infarction,” Blood Transfusion, vol. 11, no. 3, pp. 464-465, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Miñano, A. Ordóñez, F. España et al., “AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms,” Haematologica, vol. 93, no. 5, pp. 729–734, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. E.-W. Huang, L.-Y. Peng, J.-X. Zheng et al., “Investigation of associations between ten polymorphisms and the risk of coronary artery disease in Southern Han Chinese,” Journal of Human Genetics, vol. 61, no. 5, pp. 389–393, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Wang, L. Wang, X. Liu et al., “Genetic variants associated with myocardial infarction and the risk factors in Chinese population,” PLoS ONE, vol. 9, no. 1, Article ID e86332, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Kiechl, G. Paré, M. Barbalic et al., “Association of variation at the ABO Locus with circulating levels of soluble intercellular adhesion molecule-1, Soluble P-selectin, and Soluble E-selectin: a meta-analysis,” Circulation: Cardiovascular Genetics, vol. 4, no. 6, pp. 681–686, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Chen, C. Chen, X. Ke et al., “Analysis of circulating cholesterol levels as a mediator of an association between ABO blood group and coronary heart disease,” Circulation: Cardiovascular Genetics, vol. 7, no. 1, pp. 43–48, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Wang and P. Dong, “Thrombomodulin - 33G/A and Ala455Val polymorphisms are associated with the risk of coronary artery disease: a meta-analysis including 12 584 patients,” Coronary Artery Disease, vol. 26, no. 1, pp. 72–77, 2015. View at Publisher · View at Google Scholar · View at Scopus